Radboudumc and Johnson & Johnson - Radboudumc

html { overflow: visible; height: auto; } .MainNav_ItemWrapper:hover .Subnavigation_Wrapper, .MainNav_Item:focus + .Subnavigation_Wrapper { display: block; } .Header-FixedHeight .Dialoog, .Header-FixedHeight .Title_Wrapper, .Accordion_ContentContainer.Hidden { height: auto !important; visibility: visible; } .Dialoog_Step.Invisible, .Title_Wrapper.Invisible, main.Invisible, .js-GridItem { transform: none; opacity: 1; } .Dialoog_Form, .js-OptionsOpenBtn, .Image_Wrapper-Scaled, .Video_Wrapper-Scaled, img[data-src] { display: none; } .js-MasonryGrid { display: flex; flex-wrap: wrap; }

Radboudumc and Johnson & Johnson

Radboudumc and Radboud University have been working closely with Johnson & Johnson (Janssen Pharmaceutica NV, Janssen-Cilag B.V. and Janssen Vaccines & Prevention B.V.) since 2019. The collaboration focuses on, among other things:

scientific research and stimulation of talent, including in oncology and immunology
molecules/products/platforms
technology and licensing opportunities
digital health
clinical activities
sustainability, SDGs, and sustainable availability of medicines
broader innovation ecology of health care system

Radboudumc has a strong focus on sustainable, innovative and affordable patient care. Johnson & Johnson is a global player in the pharmaceutical industry. The collaboration creates a unique synergy between research, education, care, and valorization. Through this creative interaction, promising projects surface and lead to concrete results more quickly.

The collaboration enables researchers to link high quality academic innovative research even better to the translation capabilities of the industry. Biomedical, pharmaceutical, and clinical research will thus become available to the patient more quickly.

Radboudumc and partners Collaborations Johnson & Johnson

Radboudumc and Johnson & Johnson

Together, Radboudumc and Johnson & Johnson bring the results of scientific research to the patient.

read more

Questions? Contact us!

Paul van der Hoeven
senior business developer Valorization

contact form

Website Johnson & Johnson

to website

News

Meet Healthy Ideas, Healthy Returns

Do you have a golden idea to improve healthcare, but not the resources to realize it? Discover Healthy Ideas, Healthy Returns: a Benelux-wide public-private network offering opportunities for healthcare investments and propositions, among other things.

Joining forces increases innovation Janssen and Radboud

1 December 2022

Dr. Eng Kinga Matuła (KM), specialist in single-cell multi-omics and Jeroen Van Houdt (JH), Omics group leader at Janssen Pharmaceutica, answer three pressing questions about the successful collaboration in the single-cell technology project.

The essentials of partnering with a healthcare company July 6, 2022

Discover ins and outs of building a successful partnership or collaboration with a healthcare company.

Employees
mijnRadboud